富士製薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/12/02 | 1,600 | 1,635 | 1,591 | 1,635 | +21 | +1.3% | 158,500 |
| 2024/11/29 | 1,598 | 1,643 | 1,590 | 1,614 | -8 | -0.5% | 284,200 |
| 2024/11/28 | 1,546 | 1,630 | 1,539 | 1,622 | +99 | +6.5% | 455,200 |
| 2024/11/27 | 1,573 | 1,573 | 1,500 | 1,523 | +16 | +1.1% | 362,600 |
| 2024/11/26 | 1,481 | 1,527 | 1,467 | 1,507 | +26 | +1.8% | 344,500 |
| 2024/11/25 | 1,465 | 1,488 | 1,456 | 1,481 | +23 | +1.6% | 136,100 |
| 2024/11/22 | 1,437 | 1,458 | 1,426 | 1,458 | +35 | +2.5% | 124,100 |
| 2024/11/21 | 1,428 | 1,437 | 1,410 | 1,423 | +3 | +0.2% | 65,300 |
| 2024/11/20 | 1,419 | 1,447 | 1,415 | 1,420 | +9 | +0.6% | 155,600 |
| 2024/11/19 | 1,365 | 1,421 | 1,365 | 1,411 | +41 | +3% | 182,100 |
| 2024/11/18 | 1,364 | 1,376 | 1,357 | 1,370 | +7 | +0.5% | 46,400 |
| 2024/11/15 | 1,390 | 1,391 | 1,339 | 1,363 | -9 | -0.7% | 69,300 |
| 2024/11/14 | 1,369 | 1,384 | 1,353 | 1,372 | +31 | +2.3% | 160,500 |
| 2024/11/13 | 1,296 | 1,361 | 1,290 | 1,341 | +16 | +1.2% | 228,300 |
| 2024/11/12 | 1,300 | 1,338 | 1,300 | 1,325 | +33 | +2.6% | 106,200 |
| 2024/11/11 | 1,299 | 1,303 | 1,283 | 1,292 | -1 | -0.1% | 78,500 |
| 2024/11/08 | 1,305 | 1,310 | 1,286 | 1,293 | -12 | -0.9% | 45,300 |
| 2024/11/07 | 1,295 | 1,324 | 1,295 | 1,305 | +12 | +0.9% | 56,400 |
| 2024/11/06 | 1,299 | 1,308 | 1,292 | 1,293 | +4 | +0.3% | 54,700 |
| 2024/11/05 | 1,301 | 1,302 | 1,286 | 1,289 | -3 | -0.2% | 37,000 |
| 2024/11/01 | 1,302 | 1,316 | 1,290 | 1,292 | -25 | -1.9% | 37,600 |
| 2024/10/31 | 1,314 | 1,324 | 1,302 | 1,317 | -2 | -0.2% | 41,200 |
| 2024/10/30 | 1,312 | 1,337 | 1,312 | 1,319 | +8 | +0.6% | 104,300 |
| 2024/10/29 | 1,313 | 1,320 | 1,300 | 1,311 | -1 | -0.1% | 46,000 |
| 2024/10/28 | 1,269 | 1,323 | 1,268 | 1,312 | +52 | +4.1% | 86,700 |
| 2024/10/25 | 1,264 | 1,274 | 1,260 | 1,260 | -13 | -1% | 39,800 |
| 2024/10/24 | 1,267 | 1,280 | 1,266 | 1,273 | -3 | -0.2% | 33,200 |
| 2024/10/23 | 1,291 | 1,291 | 1,276 | 1,276 | -18 | -1.4% | 41,600 |
| 2024/10/22 | 1,315 | 1,325 | 1,293 | 1,294 | -21 | -1.6% | 42,300 |
| 2024/10/21 | 1,316 | 1,326 | 1,314 | 1,315 | -6 | -0.5% | 21,100 |
| 2024/10/18 | 1,313 | 1,324 | 1,313 | 1,321 | +8 | +0.6% | 15,800 |
| 2024/10/17 | 1,310 | 1,321 | 1,310 | 1,313 | +4 | +0.3% | 23,600 |
| 2024/10/16 | 1,305 | 1,324 | 1,300 | 1,309 | -5 | -0.4% | 27,700 |
| 2024/10/15 | 1,317 | 1,321 | 1,302 | 1,314 | +9 | +0.7% | 32,000 |
| 2024/10/11 | 1,318 | 1,320 | 1,305 | 1,305 | -13 | -1% | 40,300 |
| 2024/10/10 | 1,346 | 1,346 | 1,318 | 1,318 | -28 | -2.1% | 46,400 |
| 2024/10/09 | 1,330 | 1,350 | 1,328 | 1,346 | +24 | +1.8% | 83,700 |
| 2024/10/08 | 1,321 | 1,337 | 1,316 | 1,322 | -13 | -1% | 93,000 |
| 2024/10/07 | 1,352 | 1,353 | 1,325 | 1,335 | -4 | -0.3% | 85,300 |
| 2024/10/04 | 1,341 | 1,351 | 1,332 | 1,339 | +10 | +0.8% | 115,600 |
| 2024/10/03 | 1,310 | 1,337 | 1,309 | 1,329 | +58 | +4.6% | 194,500 |
| 2024/10/02 | 1,294 | 1,301 | 1,268 | 1,271 | -28 | -2.2% | 48,700 |
| 2024/10/01 | 1,277 | 1,308 | 1,277 | 1,299 | +26 | +2% | 78,200 |
| 2024/09/30 | 1,267 | 1,287 | 1,260 | 1,273 | -15 | -1.2% | 128,200 |
| 2024/09/27 | 1,286 | 1,292 | 1,268 | 1,288 | -25 | -1.9% | 103,400 |
| 2024/09/26 | 1,298 | 1,313 | 1,293 | 1,313 | +21 | +1.6% | 118,000 |
| 2024/09/25 | 1,302 | 1,303 | 1,275 | 1,292 | +8 | +0.6% | 82,100 |
| 2024/09/24 | 1,269 | 1,303 | 1,268 | 1,284 | +21 | +1.7% | 124,400 |
| 2024/09/20 | 1,277 | 1,282 | 1,259 | 1,263 | -6 | -0.5% | 111,900 |
| 2024/09/19 | 1,249 | 1,275 | 1,249 | 1,269 | +37 | +3% | 72,100 |
101～
150
件表示中 / 6945件
類似銘柄と比較する
現在ご覧いただいている「富士製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 富士製薬 | 136,100円 | +15.7% | +5.3% | 3.34% | 9.84倍 | 0.73倍 |
|
女性医療、急性期医療の２領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
| タウンズ | 50,200円 | +4.6% | +6.1% | 5.58% | 8.54倍 | 3.16倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
| 生化学 | 70,700円 | +9.2% | +39.0% | 4.24% | 23.39倍 | 0.51倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。２種のヒアルロン酸製剤は科研と参天が販売 |
| ヘリオス | 32,300円 | +150.0% | - | 0.00% | - | 15.89倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| ダイト | 209,600円 | +4.5% | -33.7% | 3.34% | 21.11倍 | 0.61倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック（後発医薬品）メーカー向け強い |
市場注目の銘柄
チャート関連のコラム
